| FRANKLIN GENOMIC ADVANCEMENTS A (ACC) USD | RVI BIOTECNOLOGÍA | 7,008761 | 08/10/2026 | 19,70% | 34,61% | *** |
| FRANKLIN GENOMIC ADVANCEMENTS A (YDIS) EUR | RVI BIOTECNOLOGÍA | 8,130000 | 08/10/2026 | 19,38% | 34,60% | *** |
| FRANKLIN GENOMIC ADVANCEMENTS C (ACC) USD | RVI BIOTECNOLOGÍA | 6,812087 | 08/10/2026 | 19,29% | 32,52% | *** |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) GBP (HEDGED) | RVI BIOTECNOLOGÍA | 157,276441 | 08/10/2026 | 19,15% | 44,30% | *** |
| JPM THEMATICS-GENETIC THERAPIES D (ACC) USD | RVI BIOTECNOLOGÍA | 76,488468 | 08/10/2026 | 19,07% | 27,78% | ** |
| FRANKLIN GENOMIC ADVANCEMENTS N (ACC) USD | RVI BIOTECNOLOGÍA | 6,758448 | 08/10/2026 | 19,06% | 31,96% | ** |
| FRANKLIN GENOMIC ADVANCEMENTS N (ACC) EUR | RVI BIOTECNOLOGÍA | 7,830000 | 08/10/2026 | 18,82% | 31,82% | *** |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) GBP (HEDGED) | RVI BIOTECNOLOGÍA | 154,926917 | 08/10/2026 | 18,71% | 42,75% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY V CAP USD | RVI BIOTECNOLOGÍA | 2.830,502414 | 08/10/2026 | 15,36% | 66,46% | **** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I CAP USD | RVI BIOTECNOLOGÍA | 7.718,621491 | 08/10/2026 | 15,18% | 65,82% | **** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R CAP USD | RVI BIOTECNOLOGÍA | 370,793849 | 08/10/2026 | 15,04% | 68,52% | **** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I CAP EUR | RVI BIOTECNOLOGÍA | 3.282,680000 | 08/10/2026 | 14,93% | 65,52% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R CAP EUR | RVI BIOTECNOLOGÍA | 486,760000 | 08/10/2026 | 14,75% | 68,23% | **** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY C CAP USD | RVI BIOTECNOLOGÍA | 1.143,152154 | 08/10/2026 | 14,26% | 64,09% | *** |
| JPM THEMATICS-GENETIC THERAPIES I2 (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 115,100000 | 08/10/2026 | 14,20% | 34,98% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 121,520000 | 08/10/2026 | 14,17% | 34,83% | ** |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 80,890000 | 08/10/2026 | 14,11% | 34,59% | ** |
| JPM THEMATICS-GENETIC THERAPIES C (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 98,660000 | 08/10/2026 | 14,06% | 34,43% | ** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY C CAP EUR | RVI BIOTECNOLOGÍA | 322,680000 | 08/10/2026 | 13,94% | 63,58% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY N CAP USD | RVI BIOTECNOLOGÍA | 807,357411 | 08/10/2026 | 13,94% | 62,30% | *** |
